Articles about Adar Poonawalla
17 Jun 2021
Covovax India launch by September; trial for kids soon: SII
The Serum Institute of India (SII) is looking to launch the COVID-19 vaccine developed by the United States firm Novavax in India by September.
03 May 2021
Reports claiming fresh COVID-19 vaccine orders not placed baseless: Government
The Union Health Ministry on Monday refuted media reports that claimed that the central government had not placed fresh orders for COVID-19 vaccines.
02 May 2021
Getting aggressive calls from powerful people: SII CEO Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla has revealed that his decision to fly to London when India is facing a COVID-19 second wave was largely due to the threats he had been facing.
28 Apr 2021
Covishield price reduced to Rs. 300 for states: Adar Poonawalla
Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.
15 Apr 2021
COVID-19 vaccine production hit as US, Europe obstruct raw material
As India faces a record surge in coronavirus infections, Serum Institute of India (SII) CEO Adar Poonawalla has raised concerns about the United States and Europe holding back key vaccine raw material.
08 Apr 2021
AstraZeneca serves legal notice to Serum Institute over vaccine delays
Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.
06 Apr 2021
Covishield 90% effective if doses given 2-3 months apart: Poonawalla
The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.
27 Mar 2021
Serum CEO Poonawalla hopes to launch second vaccine by September
Serum Institute of India CEO Adar Poonawalla today said that his company hopes to launch its second coronavirus vaccine by September this year.
05 Mar 2021
Adar Poonawalla, WHO scientist warn of delays in vaccine production
Adar Poonawalla, the head of the world's biggest vaccine maker, and the World Health Organization's (WHO) chief scientist have said that the manufacturers of coronavirus vaccine doses are facing a global shortage of the raw materials required to produce the doses.
22 Jan 2021
After SII fire, BCG, rotavirus vaccine production to be hit
Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.
21 Jan 2021
Five killed in Serum Institute fire; Maharashtra government orders probe
The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.
21 Jan 2021
Pune: Fire breaks out at Serum Institute of India
On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.
11 Jan 2021
Rs. 200 per vaccine dose: SII receives government's purchase order
The Pune-based Serum Institute of India (SII) has received the purchase order for COVID-19 vaccines from the central government, officials said on Monday.
08 Jan 2021
Coronavirus vaccine consignment awaits government nod for take-off from Pune
On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.
05 Jan 2021
Sleeves up! Coronavirus vaccination drive could begin on January 13
The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.
05 Jan 2021
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
04 Jan 2021
Private hospitals may get coronavirus vaccine by March: Serum CEO
While the Indian government has prioritized healthcare workers and high-risk individuals in its vaccine program, doses of the coronavirus vaccine will be available for private companies, hospitals, and individuals by as early as March, the CEO of Serum Institute of India (SII), Adar Poonawalla, said on Sunday.
03 Jan 2021
'Finally paid off,' says Adar Poonawalla after Covishield gets approval
Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.
03 Jan 2021
All you need to know about vaccines approved in India
Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.
01 Jan 2021
India set to start COVID-19 vaccination; panel approves Oxford vaccine
In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.
28 Dec 2020
Centre extends COVID-19 surveillance guidelines till January 31
The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.
30 Nov 2020
Modi to chair all-party meet to review COVID-19 situation Friday
Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.
28 Nov 2020
Applying for Covishield's emergency approval in 2 weeks: SII
The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.
28 Nov 2020
PM to visit three cities to review coronavirus vaccine development
Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.
23 Nov 2020
Can launch 100 million vaccine doses by January-February, says Poonawalla
The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.
20 Nov 2020
Oxford vaccine to be available by April 2021 in India
Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.
14 Nov 2020
India to get 10cr COVID-19 vaccine doses by December: SII
The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.
12 Nov 2020
COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR
The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.
08 Nov 2020
Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
05 Nov 2020
Bharat Biotech's coronavirus vaccine could be out by February 2021
The coronavirus vaccine being developed by Bharat Biotech could be launched by February, months earlier than expected, an official from the Indian Council of Medical Research (ICMR), told Reuters on Thursday.
05 Nov 2020
Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla
Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.
01 Nov 2020
Vaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
29 Oct 2020
Oxford's coronavirus vaccine could be available by December: Adar Poonawalla
In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.
22 Oct 2020
Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country
The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.
20 Oct 2020
India to play crucial role in COVID-19 vaccine process
As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.
27 Sep 2020
PM's vaccine arrangements will take care of all: Adar Poonawalla
As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.
16 Sep 2020
After setback, Serum allowed to resume Oxford's coronavirus vaccine trial
Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.
15 Sep 2020
NewsBytes Briefing: Potential signs of life on Venus, and more
Last night, our planetary neighbor Venus made major headlines as a group of researchers found potential signs of alien life using ground-based telescopes.
14 Sep 2020
Coronavirus vaccine won't be available for all before 2024-end: Poonawalla
Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.
30 Aug 2020
Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute
One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, has announced that it will invest in the Serum Institute of India (SII) for the development of a coronavirus vaccine.